Head, Metabolic Genetic Diseases Research Laboratory, Deakin University

Dr. Yann Gibert obtained his BSc in Biology in 1997 from the University of Pau (France) and his MSc in Biochemistry in 2001 from the University of Limerick (Ireland). Dr. Gibert gained his PhD examining the roles played by the Retinoic Acid pathway during zebrafish embryonic development and using the zebrafish studied the evolution of genes implicated in non-channelopathy epilepsies in 2005 from the University of Konstanz (Germany).

After his PhD, Dr. Gibert worked as a post-doctoral fellow at the Institute of Functional Genomics of Lyon within the Ecole Normale Superieure of Lyon (France), http://igfl.ens-lyon.fr/External link, broadening his interests into Retinoic Acid signalling and using the zebrafish as model for metabolic diseases. He then worked as a Research Fellow at Harvard Medical School,
http://hms.harvard.edu/hms/home.aspExternal link, within the Beth Israel Deaconess Medical Centre, http://www.bidmc.org/External link, using the zebrafish to study the genetics of anemia and hemochromatosis.

Dr Gibert is a primary author on over 15 publications in international peer reviewed journals including: Development, PLoS One, Trends in Genetics, Molecular Biology and Evolution, the FASEB Journal, Blood. Dr. Gibert retains solid projects with international collaborations in Australia, Europe and the USA using the zebrafish as vertebrate model organism.

Experience

  • –present
    Head, Metabolic Genetic Diseases Research Laboratory, Deakin University

Education

  • 2005 
    University of Konstanz, PhD/Biology